Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00240227 · ClinicalTrials.gov registry record · NA
Prazosin for ETOH or Cocaine Craving
A NA study, sponsored by US Department of Veterans Affairs.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00240227: Clinical Trial NA study, sponsored by US Department of Veterans Affairs.
NCT00240227 is a NA study that was terminated before completion, run by US Department of Veterans Affairs. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00240227, a NA study, was terminated before completion, sponsored by US Department of Veterans Affairs.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This double-blind placebo controlled crossover pilot trial will test the hypothesis that prazosin, an alpha-1 adrenergic receptor antagonist, reduces craving for their drug of choice in cocaine-dependent and alcohol-dependent veterans. Both the study medication period and the placebo period are each 4 weeks in duration.
Interventions
- DRUG placebo
- DRUG Prazosin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2004-04 |
| Est. Completion | 2009-01 |
| Phase | NA |
Why NCT00240227 stopped before completion
NCT00240227 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00240227 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00240227 about?
NCT00240227 is a clinical study titled "Prazosin for ETOH or Cocaine Craving". This double-blind placebo controlled crossover pilot trial will test the hypothesis that prazosin, an alpha-1 adrenergic receptor antagonist, reduces craving for their drug of choice in cocaine-dependent and alcohol-dependent veterans. Both the study medication period and the placebo period are each...
What is the current status of trial NCT00240227?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2004-04. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00240227?
The interventions under investigation include: placebo (DRUG), Prazosin (DRUG).
Who is sponsoring clinical trial NCT00240227?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00240227's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia